Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRSF6P2, or SRSF6 pseudogene 2, is a classified pseudogene and is not known to encode a functional protein or have direct biological or pathophysiological functions[5]. Pseudogenes such as SRSF6P2 are typically non-coding DNA sequences that resemble known genes but carry mutations or deletions that prevent normal expression or function; they do not serve as receptors, enzymes, or other typical drug targets in pharmacology[5]. No evidence suggests SRSF6P2 is directly involved in cellular processes or disease mechanisms, nor are there known drugs or therapeutic applications targeting this sequence. Errors arise if SRSF6P2 is confused with SRSF6 (Serine/arginine-rich splicing factor 6), a functional and disease-relevant protein-coding gene extensively studied for its roles in alternative splicing, cancer, and other cellular processes[1][2][4]. Structured biomedical databases (e.g., GeneCards) specifically annotate SRSF6P2 as a pseudogene distinct from the functional SRSF6 gene[5].\n\nKey Points:\n- SRSF6P2 is only a pseudogene.\n- Does not encode any known protein.\n- Not a therapeutic target, receptor, enzyme, or biomarker.\n- No drug interactions or associated mechanisms of action.\n- No established disease roles or safety concerns.\n- Should not be listed among canonical therapeutic or functional targets.\n\nIf information on the functional SRSF6 gene is needed, it should be requested for Serine/arginine-rich splicing factor 6 (SRSF6), not SRSF6P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRSF6 pseudogene 2 (SRSF6P2).